Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transplantation for liver tumors.

Jacques Belghiti1

  • 1Department of Digestive Surgery and Transplantation, Hospital Beaujon, Clichy, France.

Seminars in Oncology
|December 20, 2005
PubMed
Summary

Liver transplantation is primarily for hepatocellular carcinoma (HCC) meeting specific criteria. Its role in other liver cancers like cholangiocarcinoma and neuroendocrine tumors varies, with some selected cases benefiting.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ancient and Modern History of Pancreatic Surgery.

Pancreas·2025
Same author

Solid Organ Transplant Litigation at One of Europe's Largest University Hospitals.

Transplant international : official journal of the European Society for Organ Transplantation·2024
Same author

[Better integration of the "Padhue"].

La Revue du praticien·2024
Same author

Refining Auxiliary Orthotopic Liver Transplantation (AOLT) Improves Outcomes in Adult Patients With Acute Liver Failure.

Annals of surgery·2023
Same author

The role of preoperative psychosocial counseling on the improvement of the recipient compliance and speed of recovery after liver transplantation - A systematic review of the literature and expert panel recommendations.

Clinical transplantation·2022
Same author

[Connected health objects and medical devices].

La Revue du praticien·2021

Area of Science:

  • Hepatology
  • Surgical Oncology
  • Transplant Surgery

Background:

  • Liver transplantation is a key treatment for end-stage liver disease.
  • Malignancy is an increasing consideration for liver transplant eligibility.
  • Specific tumor types and staging influence transplant candidacy.

Purpose of the Study:

  • To review the current indications and outcomes of liver transplantation for various liver malignancies.
  • To delineate the role of transplantation in hepatocellular carcinoma, cholangiocarcinoma, epithelioid hemangioendothelioma, and neuroendocrine tumors.
  • To assess the benefit of transplantation in patients with unresectable liver metastases.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Analysis of patient selection criteria for liver transplantation in malignancy.
  • Evaluation of survival data for different liver cancer types post-transplantation.

Main Results:

  • Hepatocellular carcinoma (HCC) transplantation follows established size and vascular invasion criteria; pre-transplant resection is promising.
  • Transplantation offers limited benefit for cholangiocarcinoma, except in select primary sclerosing cholangitis cases.
  • Epithelioid hemangioendothelioma shows good survival post-transplant, but overall benefit requires further study.
  • Transplantation may benefit unresectable neuroendocrine tumors but not non-neuroendocrine liver metastases.

Conclusions:

  • Liver transplantation is well-established for specific HCC cases.
  • Transplantation's role in other primary liver cancers and metastases is selective and evolving.
  • Careful patient selection is crucial for optimizing outcomes in liver transplantation for malignancy.

Related Experiment Videos